Sprint Merger Stirs KC Hope and Fears Over Jobs
The $115 billion Sprint WorldCom merger unsettles Kansas City area workers and leaders. Sprint remains the region’s largest private employer with about 15,000 jobs in Kansas City, while WorldCom’s global staff nears 140,000. Executives urge no immediate terminations, but long term effects remain uncertain.
MENTIONED IN THIS ARTICLE
Sprint Corp
Kansas City
Sprint
MCI WorldCom Inc
New York
Nomic
Overland Park
WorldCom
Michael B. Fuller
London train crash kills 26 in rush hour collision
Two commuter trains collided near Ladbroke Grove in west London on Tuesday, killing 26 and injuring 160 as emergency crews battled flames and debris. Investigators cited possible driver error or signal failure, with 18 seriously hurt and 124 treated at area hospitals.
MENTIONED IN THIS ARTICLE
Paddington
London
Ladbroke Grove
Great Western
Robin Touquet
St. Mary’s Hospital
Finney Drops Federal Suit Against Topeka Police
Former Governor Joan Finney says she will drop her federal lawsuit against the Topeka Police Department in exchange for $1 and public apologies from city leaders. She alleges unlawful police search of her Topeka home in 1997 and mistreatment of her son during a burglary probe.
MENTIONED IN THIS ARTICLE
Topeka
Joan Finney
Lopeka
Kansas technical schools struggle to meet demand
Technical schools in Kansas face long waiting lists as employers like Sprint and MCI demand trained workers now. Kansas has 11 technical schools with limited capacity, leaving 500 to 1,000 students statewide on waiting lists for high tech programs. At Northwest Area Technical School in Goodland, 115 join yearly but three-year waits persist. Manhattan Area Technical College reports 244 prospective entrants on the Aug 8 waitlist while operating 400 full-time and 1,500 part-time students.
MENTIONED IN THIS ARTICLE
Kansas
John Lind
Kansas City, Kan
Kansas Association of Technical Schools
Lind
Sprint
MCI
Duane Dunn
The
Manhattan Area Technical Col
Lege
KATS
Experimental Tamiflu pill boosts flu protection
Researchers led by Frederick Hayden report an inhaled powder against A and B flu types now moving toward government approval. In a controlled study, the Tamiflu pill reduced symptoms by about half in unvaccinated adults infected with the flu and prevented illness in those exposed. Vaccination remains preferred, but some cannot receive vaccines. Funding came from Hoffman LaRoche and NIH.
MENTIONED IN THIS ARTICLE
Chicago
Food and Drug Administration
Journal of the American Medical Assa
Frederick G. Hayden
University of Virginia
Hayden
Hoffman LaRoche Ltd
National Institutes of Health
Also Mentioned on This Page
Associario Press
North America
MCI WorldCom
Bernard J. Ebbers
Rhore
Britain
Stuart Allen
Ash
Finney
Jurnal-World Wirth
Frank Carlson
Ghodlani
Beldit
Satha
Kansas’ Technical Colleges and Schools
Baray Nichols
lustRa